1. Home
  2. EDUC vs EVGN Comparison

EDUC vs EVGN Comparison

Compare EDUC & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Educational Development Corporation

EDUC

Educational Development Corporation

N/A

Current Price

$1.31

Market Cap

10.8M

ML Signal

N/A

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$1.00

Market Cap

10.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDUC
EVGN
Founded
1965
1999
Country
United States
Israel
Employees
N/A
N/A
Industry
Consumer Specialties
Agricultural Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.8M
10.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EDUC
EVGN
Price
$1.31
$1.00
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
24.4K
46.7K
Earning Date
01-12-2026
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$29,415,900.00
$8,016,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$12.35
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.19
52 Week Low
$0.92
$0.95
52 Week High
$1.93
$2.42

Technical Indicators

Market Signals
Indicator
EDUC
EVGN
Relative Strength Index (RSI) 49.94 36.27
Support Level $1.23 $1.07
Resistance Level $1.34 $1.12
Average True Range (ATR) 0.08 0.05
MACD 0.01 -0.01
Stochastic Oscillator 73.33 17.36

Price Performance

Historical Comparison
EDUC
EVGN

About EDUC Educational Development Corporation

Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

Share on Social Networks: